ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

ClinicalTrials.gov ID: NCT06867718

Public ClinicalTrials.gov record NCT06867718. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study of Once-Daily RGT001-075 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities (COMO-1)

Study identification

NCT ID
NCT06867718
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Regor Pharmaceuticals Inc.
Industry
Enrollment
236 participants

Conditions and interventions

Interventions

  • Placebo Comparator Drug
  • RGT001-075 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 23, 2025
Primary completion
Sep 18, 2025
Completion
Dec 11, 2025
Last update posted
Apr 1, 2025

2025

United States locations

U.S. sites
35
U.S. states
21
U.S. cities
34
Facility City State ZIP Site status
Alliance for Multispecialty Research, LLC Mobile Alabama 36608
Synexus Clinical Research Phoenix Arizona 85020
Velocity Clinical Research Huntington Park California 90255
Angels Clinical Research Doral Florida 33122
Optimal Research Melbourne Florida 32934
Angels Clinical Research Miami Florida 33126
Palm Springs Community Health Center Miami Lakes Florida 33014
Synexus Clinical Research The Villages Florida 32162
Javara-Privia Medical Group, Georgia LLC Savannah Georgia 31406
Javara-Privia Medical Group, Georgia, LLC Thomasville Georgia 31792
Synexus Clinical Research Evansville Indiana 47714
Velocity Clinical Research Valparaiso Indiana 46383
Alliance for Multispecialty Research, LLC Lexington Kentucky 40509
Velocity Clinical Research Baton Rouge Louisiana 70809
Velocity Clinical Research Rockville Maryland 20854
Mankato Clinic-East Main Street-Javara Mankato Minnesota 56001
Synexus Clinical Research Richfield Minnesota 55423
Synexus Clinical Research Creve Coeur Missouri 63141
Velocity Clinical Research Omaha Nebraska 68134
Premier Health Research-Sparta-Objective Health Sparta New Jersey 07871
Velocity Clinical Research Vestal New York 13850
Javara-Tryon Medical Partners, PLLC Charlotte North Carolina 28287
Velocity Clinical Research Durham North Carolina 27701
Velocity Clinical Research Cincinnati Ohio 45246
Velocity Clinical Research Cleveland Ohio 44122
Alliance for Multispecialty Research, LLC Norman Oklahoma 73069
Velocity Clinical Research East Greenwich Rhode Island 02818
Velocity Clinical Research Dallas Texas 75230
Synexus Clinical Research Dallas Texas 75234
Synexus Clinical Research San Antonio Texas 78229
Javara-Privia Medical Group Gulf Coast PLLC The Woodlands Texas 77384
Velocity Clinical Research Waco Texas 76710
Synexus Clinical Research Salt Lake City Utah 84106
Velocity Clinical Research West Jordan Utah 84088
Velocity Clinical Research Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06867718, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2025 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06867718 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →